Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
63%(5 trials)

Phase Distribution

Ph phase_1
3
33%
Ph phase_4
4
44%
Ph phase_3
2
22%

Phase Distribution

3

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Other(1)

Detailed Status

Completed8
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 32 (22.2%)
Phase 44 (44.4%)

Trials by Status

unknown111%
completed889%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9